Chen Schor - Nov 10, 2022 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role
President & CEO, Director
Signature
/s/ Nick Harvey, Attorney-in-Fact
Stock symbol
ACET
Transactions as of
Nov 10, 2022
Transactions value $
-$811,242
Form type
4
Date filed
11/15/2022, 03:31 PM
Previous filing
Nov 9, 2022
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACET Common Stock Sale -$209K -9.96K -9.82% $21.03 91.5K Nov 10, 2022 Direct F1, F2
transaction ACET Common Stock Sale -$602K -30K -35.96% $20.06 53.4K Nov 10, 2022 See Footnote F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $21.00 to $21.18, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission ("SEC") staff upon request.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $20.00 to $20.27, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4 Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee.